Corporate News     04-Jan-23
Gland Pharma's Dundigal facility receives EIR report from USFDA
Gland Pharma announced that following the Pre-Market Inspection covering US FDA's Quality System/Current Good Manufacturing Practice regulations for Medical Devices (21 CFR Part 820) at the Company's Dundigal Facility at Hyderabad from 22 August 2022 to 25 August 2022; the Company has received the Establishment Inspection Report (EIR) from the Office of Product Evaluation and Quality Center for Devices and Radiological Health, US FDA indicating closure of the inspection.
Previous News
  Indices trade higher; PSU bank shares advance
 ( Market Commentary - Mid-Session 29-Apr-24   14:34 )
  Gland Pharma Ltd gains for third straight session
 ( Hot Pursuit - 20-Dec-23   13:05 )
  Gland Pharma Ltd gains for third straight session
 ( Hot Pursuit - 09-Sep-24   13:05 )
  Gland Pharma allots 2,400 equity shares under ESOS
 ( Corporate News - 26-Mar-24   09:55 )
  Gland Pharma appoints Chief Operating Officer
 ( Corporate News - 29-Apr-24   14:51 )
  Volumes jump at Elgi Equipments Ltd counter
 ( Hot Pursuit - 23-Jul-24   11:00 )
  Gland Pharma's Pashamylaram facility clears USFDA inspection
 ( Corporate News - 26-Sep-23   11:46 )
  Gland Pharma Ltd leads losers in 'A' group
 ( Hot Pursuit - 22-May-23   15:00 )
  Volumes jump at Gland Pharma Ltd counter
 ( Hot Pursuit - 22-May-23   14:30 )
  Gland Pharma Hyderabad facility gets one USFDA observation
 ( Hot Pursuit - 28-Jun-23   09:38 )
  Gland Pharma Ltd up for third straight session
 ( Hot Pursuit - 31-Jul-23   13:05 )
Other Stories
  CARE reaffirms ratings on bank facilities of PNC Infratech's subsidiaries
  05-Oct-24   10:45
  CG Power & Industrial Solutions to acquire radio frequency components biz of Renesas
  05-Oct-24   10:30
  MMP Industries to convene board meeting
  05-Oct-24   10:23
  Mahindra & Mahindra Financial Serv. to discuss results
  05-Oct-24   10:23
  Ambey Laboratories to hold board meeting
  05-Oct-24   10:23
  Aurobindo Pharma's step down subsidiary to divest its entire stake in JV 'Novagen'
  05-Oct-24   10:21
  Aurobindo Pharma's step down subsidiary to divest its entire stake in a South African JV
  05-Oct-24   10:19
  Just Dial announces board meeting date
  05-Oct-24   10:11
  L&T Finance schedules board meeting
  05-Oct-24   10:11
  Australian Premium Solar (India) announces board meeting date
  05-Oct-24   10:11
Back Top